Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Notes Payables (2021 - 2025)

KORU Medical Systems (KRMD) has disclosed Notes Payables for 8 consecutive years, with $334931.0 as the latest value for Q3 2025.

  • On a quarterly basis, Notes Payables fell 16.68% to $334931.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $334931.0, a 16.68% decrease, with the full-year FY2024 number at $271152.0, down 13.74% from a year prior.
  • Notes Payables was $334931.0 for Q3 2025 at KORU Medical Systems, up from $137180.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $673133.0 in Q3 2021 to a low of $137180.0 in Q1 2025.
  • A 5-year average of $370647.5 and a median of $334931.0 in 2025 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: fell 4.22% in 2022, then fell 27.72% in 2023.
  • KORU Medical Systems' Notes Payables stood at $508583.0 in 2021, then decreased by 14.8% to $433295.0 in 2022, then decreased by 27.45% to $314344.0 in 2023, then dropped by 13.74% to $271152.0 in 2024, then increased by 23.52% to $334931.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Notes Payables are $334931.0 (Q3 2025), $137180.0 (Q1 2025), and $271152.0 (Q4 2024).